77 related articles for article (PubMed ID: 1582505)
1. Is Lauren's histopathological classification of importance in patients with stomach cancer? A national experience. Norwegian Stomach Cancer Trial.
Haugstvedt TK; Viste A; Eide GE; Maartmann-Moe H; Myking A; Søreide O
Eur J Surg Oncol; 1992 Apr; 18(2):124-30. PubMed ID: 1582505
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of Laurén's histopathological classification system and ABO blood groups in patients with stomach carcinoma.
Viste A; Eide GE; Halvorsen K; Maartmann-Moe H; Søreide O
Eur J Surg Oncol; 1986 Jun; 12(2):135-41. PubMed ID: 3709818
[TBL] [Abstract][Full Text] [Related]
3. Gastric cancer: correlation between clinicopathological factors and survival of patients. II.
Lazăr D; Tăban S; Sporea I; Dema A; Cornianu M; Lazăr E; Goldiş A; Vernic C
Rom J Morphol Embryol; 2009; 50(2):185-94. PubMed ID: 19434309
[TBL] [Abstract][Full Text] [Related]
4. Relationship between immunoexpression of mucin peptide cores MUC1 and MUC2 and Lauren's histologic subtypes of gastric carcinomas.
Barresi V; Vitarelli E; Grosso M; Tuccari G; Barresi G
Eur J Histochem; 2006; 50(4):301-9. PubMed ID: 17213039
[TBL] [Abstract][Full Text] [Related]
5. [Gastric carcinoma: a histopathological study of 705 cases].
Leocata P; Ventura L; Giunta M; Guadagni S; Fortunato C; Discepoli S; Ventura T
Ann Ital Chir; 1998; 69(3):331-7. PubMed ID: 9835105
[TBL] [Abstract][Full Text] [Related]
6. A prospective correlation of Laurén's histological classification of stomach cancer with clinicopathological findings including DNA flow cytometry.
Lee KH; Lee JH; Cho JK; Kim TW; Kang YK; Lee JS; Kim WK; Chung JG; Lee IC; Sun HS
Pathol Res Pract; 2001; 197(4):223-9. PubMed ID: 11358006
[TBL] [Abstract][Full Text] [Related]
7. Intestinal type: diffuse type ratio of gastric carcinoma in a Mexican population.
Mohar A; Suchil-Bernal L; Hernández-Guerrero A; Podolsky-Rapoport I; Herrera-Goepfert R; Mora-Tiscareño A; Aiello-Crocifoglio V
J Exp Clin Cancer Res; 1997 Jun; 16(2):189-94. PubMed ID: 9261746
[TBL] [Abstract][Full Text] [Related]
8. The mixed type in Laurén's classification of gastric carcinoma. Histologic description and biologic behavior.
Stelzner S; Emmrich P
Gen Diagn Pathol; 1997 Jul; 143(1):39-48. PubMed ID: 9269907
[TBL] [Abstract][Full Text] [Related]
9. [Clinicomorphological variants of gastric cancer].
Danilova IA
Arkh Patol; 2005; 67(5):32-4. PubMed ID: 16323478
[TBL] [Abstract][Full Text] [Related]
10. [Histologic types of gastric cancer according to the Lauren classification at the Cayetano Heredia National Hospital].
Clendenes Alvarado D; Cok Garcia J; Bussalleu Rivera A
Rev Gastroenterol Peru; 1995; 15(3):239-46. PubMed ID: 8580452
[TBL] [Abstract][Full Text] [Related]
11. Pathological disorders of the gastric mucosa surrounding carcinomas and primary lymphomas.
Arista-Nasr J; Jiménez-Rosas F; Uribe-Uribe N; Herrera-Goepfert R; Lazos-Ochoa M
Am J Gastroenterol; 2001 Jun; 96(6):1746-50. PubMed ID: 11419824
[TBL] [Abstract][Full Text] [Related]
12. Arp2/3 overexpression contributed to pathogenesis, growth and invasion of gastric carcinoma.
Zheng HC; Zheng YS; Li XH; Takahashi H; Hara T; Masuda S; Yang XH; Guan YF; Takano Y
Anticancer Res; 2008; 28(4B):2225-32. PubMed ID: 18751399
[TBL] [Abstract][Full Text] [Related]
13. [Is the Lauren classification an independent parameter for the prognostic evaluation of surgically treated gastric cancer patients? Analysis of a case series].
Midiri G; Eleuteri E; Coppola M; Giarnieri E; Marino G; Di Giovan Paolo M; De Francesco GP; Luzzatto L; Maceratini R; Angelini L
G Chir; 2003; 24(11-12):403-5. PubMed ID: 15018407
[TBL] [Abstract][Full Text] [Related]
14. Expression of thymidylate synthase in gastric cancer patients treated with 5-fluorouracil and doxorubicin-based adjuvant chemotherapy after curative resection.
Choi J; Lim H; Nam DK; Kim HS; Cho DY; Yi JW; Kim HC; Cho YK; Kim MW; Joo HJ; Lee KB; Kim KB
Br J Cancer; 2001 Jan; 84(2):186-92. PubMed ID: 11161374
[TBL] [Abstract][Full Text] [Related]
15. Study of gastric carcinomas with special reference to intestinal metaplasia.
Sethi S; Annamma MO; Preetha K
Indian J Pathol Microbiol; 1999 Jan; 42(1):73-9. PubMed ID: 10420688
[TBL] [Abstract][Full Text] [Related]
16. Postoperative immunochemotherapy (BCG + 5-FU) in advanced gastric cancer.
Popiela T; Zembala M; Kulig J; Czupryna A; Uracz W
Anticancer Res; 1988; 8(6):1423-7. PubMed ID: 3064717
[TBL] [Abstract][Full Text] [Related]
17. Gastric carcinoma in the Kenyan African population.
Ogutu EO; Lule GN; Okoth F; Musewe AO
East Afr Med J; 1991 May; 68(5):334-9. PubMed ID: 1935726
[TBL] [Abstract][Full Text] [Related]
18. Paradoxical expression of maspin in gastric carcinomas: correlation with carcinogenesis and progression.
Yu M; Zheng H; Tsuneyama K; Takahashi H; Nomoto K; Xu H; Takano Y
Hum Pathol; 2007 Aug; 38(8):1248-55. PubMed ID: 17490717
[TBL] [Abstract][Full Text] [Related]
19. Clinical profile of carcinoma stomach at a tertiary care hospital in south India.
Sambasivaiah K; Ibrarullah M; Reddy MK; Reddy PV; Wagholikar G; Jaiman S; Reddy DG; Sarma KV; Hegde GN
Trop Gastroenterol; 2004; 25(1):21-6. PubMed ID: 15303466
[TBL] [Abstract][Full Text] [Related]
20. [Incipient and intermediate gastric cancer II. Anatomo-pathological and surgical aspects. Cooperative study in 13 hospitals].
Csendes A; Smok G; Braghetto I; Medina E; Pizurno D; Guzmán S
Rev Med Chil; 1991 Oct; 119(10):1128-35. PubMed ID: 1845206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
